| Literature DB >> 32326502 |
Celia Bustos-Brito1, Antonio Nieto-Camacho1, Simón Hernandez-Ortega1, José Rivera-Chávez1, Leovigildo Quijano1, Baldomero Esquivel1.
Abstract
The aerial parts of Salvia cinnabarina afforded two undescribed labdane diterpenoids 1 and 2 (malonylcommunol and 6β-hydroxy-trans-communic acid) along with two known labdane diterpenoids, trans-communic acid (3) and trans-communol (4). Additionally, seven known metabolites were also isolated; two isopimarane diterpenoids 5 and 6, two sesquiterpenoids identified as β-eudesmol (7) and cryptomeridiol (8), and three aromatic compounds identified as phthalic acid (9), a mixture of tyrosol fatty acid esters (10) and the flavone salvigenine (11). While compounds compounds 1-3 showed significant inhibition of yeast α-glucosidase, compounds 2, 3 and 7 had no anti-inflammatory activity in the edema model induced by TPA. This paper is not only the first report on a wild population of Salvia cinnabarina, but also of the presence of labdane-type diterpenoids in a Mexican Salvia sp.Entities:
Keywords: Salvia cinnabarina; labdane diterpenoid; α-glucosidase
Year: 2020 PMID: 32326502 PMCID: PMC7222005 DOI: 10.3390/molecules25081808
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of 1–12.
NMR Data (1H 700 MHz and 13C 175 MHz, CDCl3) of 1.
| Position | δC | Type a | HMBC | |
|---|---|---|---|---|
| 1a | 39.0 | CH2 | 1.83, brd (12.5) | 2, 3, 5, 20 |
| 1b | 1.13, td (12.5, 5.4) | 2, 3, 5, 10, 20 | ||
| 2 | 19.0 | CH2 | 1.52, m | 1, 3, 4 |
| 3a | 36.2 | CH2 | 1.73, brd (12.8) | 1, 2, 4, 5, 18, 19 |
| 3b | 1.04, td (12.8, 5.3) | 1, 2, 4, 18, 19 | ||
| 4 | 37.6 | C | ||
| 5 | 56.2 | CH | 1.30, brd (12.5) | 1, 6, 7, 18, 19, 20 |
| 6a | 24.3 | CH2 | 1.83, m | 5, 8 |
| 6b | 1.34, dq (12.5, 3.9) | 5, 7 | ||
| 7a | 38.3 | CH2 | 2.39, m | 5, 6, 9, 17, |
| 7b | 1.97, td (12.5, 4.6) | 5, 6, 8, 17 | ||
| 8 | 147.7 | C | ||
| 9 | 57.2 | CH | 1.75, brd (13.0) | 8, 11, 12, 17, 20 |
| 10 | 39.5 | C | ||
| 11a | 23.3 | CH2 | 2.36, m | 8, 9, 12, 13, 14,* 17 * |
| 11b | 2.14, m | 8, 9, 12, 13, 14 * | ||
| 12 | 133.8 | CH | 5.39, brt (6.2) | 9, 11, 14, 16 |
| 13 | 133.7 | C | ||
| 14 | 141.7 | CH | 6.32, dd (17.4, 10.7) | 12, 13, 16 |
| 15a | 110.1 | CH2 | 5.04, d (17.4) | 12,* 13, 14 |
| 15b | 4.88, d (10.7) | 12,* 13, 14 | ||
| 16 | 12.0 | CH3 | 1.74, s | 12, 13, 14 |
| 17a | 108.2 | CH2 | 4.82, brs | 6,* 7, 8 |
| 17b | 4.47, brs | 6,* 7, 8, 9 | ||
| 18 | 27.6 | CH3 | 0.97, s | 3, 5, 19, |
| 19a | 68.5 | CH2 | 4.38, d (10.9) | 3, 5, 3′, 18 |
| 19b | 3.95, d (10.9) | 3, 5, 3′, 18 | ||
| 20 | 15.4 | CH3 | 0.72, s | 1, 5, 9, 10, |
| 1′ | 169.6 | C | ||
| 2′ | 40.7 | CH2 | 3.41, brs | 1′, 3′, 19 |
| 3′ | 168.3 | C |
a According to HSQC spectrum; * Through four-bonds interaction.
Figure 2Key NOESY interactions observed for compound 1.
Figure 3Experimental ECD spectra for compounds 1–4. Calculated ECD spectra for 3 (burgundy dashed line), ent-3 (orange dashed line), compound 4 (navy dashed line) and ent-4 (sky-blue dashed line). A negative shift of −20 nm was required to match the spectra.
NMR Data (1H 700 MHz and 13C 175 MHz, CDCl3) of 2.
| Position | δC | Type a | δH ( | HMBC |
|---|---|---|---|---|
| 1a | 20.2 | CH2 | 1.76, qd (14.3, 3.5) | 3 |
| 1b | 1.56, dt (14.3, 2.8) | 10 | ||
| 2a | 41.6 | CH2 | 1.88, brd (13.0) | 1, 3, 10, 20 * |
| 2b | 1.19, td (13.0, 3.7) | 1, 3, 9, 10, 20 * | ||
| 3a | 40.4 | CH2 | 2.38, brd (13.0) | 1, 2, 4 |
| 3b | 1.01, td (13.0, 3.7) | 1, 4, 5, 18, 19 | ||
| 4 | 46.6 | C | ||
| 5 | 57.5 | CH | 1.46, brs | 4, 6, 9, 10, 18, 19, 20 |
| 6 | 67.9 | CH | 4.52, brq (2.6) | 4, 5, 7, 8, 10 |
| 7a | 45.4 | CH2 | 2.50, dd (13.6, 2.6) | 5, 6, 8, 9, 17 |
| 7b | 2.34, brd (13.6) | 6, 8, 9, 17 | ||
| 8 | 133.9 | C | ||
| 9 | 56.7 | CH | 1.82, brd (11.1) | 5, 7, 8, 10, 11, 17, 20 |
| 10 | 41.3 | C | ||
| 11a | 23.4 | CH2 | 2.40, m | 8, 9, 12, 13, 15 |
| 11b | 2.23, ddd (16.6, 11.3, 6.4) | 9, 12, 13 | ||
| 12 | 132.9 | CH | 5.41, brt (6.4) | 9, 11, 14, 16 |
| 13 | 142.3 | C | ||
| 14 | 141.4 | CH | 6.32, dd (17.4, 10.8) | 12, 16 |
| 15a | 110.3 | CH2 | 5.06, d (17.4) | 12, 14 |
| 15b | 4.90, d (10.8) | 12, 14 | ||
| 16 | 11.9 | CH3 | 1.76, s | 12, 14 |
| 17a | 111.9 | CH2 | 5.03, brs | 7, 8, 9 |
| 17b | 4.76, brs | 7, 8, 9 | ||
| 18 | 28.4 | CH3 | 1.33, s | 3, 4, 5 |
| 19 | 180.2 | C | ||
| 20 | 15.8 | CH3 | 0.87, s | 9, 10 |
a According to HSQC spectrum; * Through four-bonds interaction.
Figure 4Key NOESY interactions observed for compound 2.
Figure 5Comparison of some physical properties of deacetylzanzibaric acid with compound 2.
Figure 6PLUTO plots of the single crystal X-ray diffraction structures of trans-communic acid (3).
Scheme 1Biogenetic hypothesis to compound 12 starting from isopimarane 6.
Figure 7Concentration-response evaluation of compounds 1–3 isolated from S. cinnabarina on yeast α-glucosidase inhibition. Each value represents the mean of three independent experiments ± SEM; The data were analyzed by ANOVA followed by Dunnet post hoc test for comparison with control group.